Literature DB >> 15885030

Metal ion modulation of cystinyl aminopeptidase.

Hilde Laeremans1, Heidi Demaegdt, Jean-Paul De Backer, Minh T Le, Veerle Kersemans, Yvette Michotte, Georges Vauquelin, Patrick M L Vanderheyden.   

Abstract

Cystinyl aminopeptidase has one Zn2+-binding motif and is a member of the M1 aminopeptidase family. Ion modulation of its catalytic activity was studied in membranes of CHO-K1 cells (Chinese-hamster ovary K1 cells) using L-leucine-p-nitroanilide as substrate. The planar bidentate chelators 1,10-phenanthroline and 2,2'-bipyridine inhibited the activity in a concentration-dependent manner with Hill slopes of 3.32+/-1.78 and 2.10+/-0.26 respectively. The acetic acid-containing chelators EDTA, EGTA and DTPA (diethylenetriamine-N,N,N',N'',N''-penta-acetic acid) weakly affected the activity, but they increased the potency of the planar chelators up to a limit, at which Hill slopes became close to unity. Moreover, competition between 1,10-phenanthroline and the substrate only took place in the presence of EDTA. These findings are compatible with a model in which the bidentate chelators inhibit enzyme activity by decreasing the free Zn2+ concentration. By removing a modulatory ion from an allosteric site at the enzyme, the acetic acid-containing chelators facilitate the direct interaction between the bidentate chelators and the catalytic Zn2+. The inhibitory effect of EDTA plus 1,10-phenanthroline could be completely reversed by Zn2+. Ca2+ and Mg2+ increased the potency of Zn2+ for this process. This is expected if they interact with the modulatory site to decrease the sensitivity of the enzyme towards 1,10-phenanthroline. Conversely, the bidendate chelators increased the high-affinity [125I]angiotensin IV binding to the membranes and this was potentiated by the acetic acid-containing chelators. These findings support the concept that high-affinity [125I]angiotensin IV binding, previously referred to as 'AT4 receptor binding', only occurs for the cystinyl aminopeptidase apoenzyme.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15885030      PMCID: PMC1184589          DOI: 10.1042/BJ20050349

Source DB:  PubMed          Journal:  Biochem J        ISSN: 0264-6021            Impact factor:   3.857


  22 in total

Review 1.  Membrane bound members of the M1 family: more than aminopeptidases.

Authors:  Anthony L Albiston; Siying Ye; Siew Yeen Chai
Journal:  Protein Pept Lett       Date:  2004-10       Impact factor: 1.890

2.  Metal ion binding and activation of Streptomyces griseus dinuclear aminopeptidase: cadmium(II) binding as a model.

Authors:  C Hasselgren; H I Park; L J Ming
Journal:  J Biol Inorg Chem       Date:  2001-02       Impact factor: 3.358

3.  Characterization of a recombinant soluble form of human placental leucine aminopeptidase/oxytocinase expressed in Chinese hamster ovary cells.

Authors:  H Matsumoto; T Rogi; K Yamashiro; S Kodama; N Tsuruoka; A Hattori; K Takio; S Mizutani; M Tsujimoto
Journal:  Eur J Biochem       Date:  2000-01

4.  Evidence that the angiotensin IV (AT(4)) receptor is the enzyme insulin-regulated aminopeptidase.

Authors:  A L Albiston; S G McDowall; D Matsacos; P Sim; E Clune; T Mustafa; J Lee; F A Mendelsohn; R J Simpson; L M Connolly; S Y Chai
Journal:  J Biol Chem       Date:  2001-11-13       Impact factor: 5.157

5.  Crystal structure of human leukotriene A(4) hydrolase, a bifunctional enzyme in inflammation.

Authors:  M M Thunnissen; P Nordlund; J Z Haeggström
Journal:  Nat Struct Biol       Date:  2001-02

6.  Structure-activity study of LVV-hemorphin-7: angiotensin AT4 receptor ligand and inhibitor of insulin-regulated aminopeptidase.

Authors:  Joohyung Lee; Tomris Mustafa; Sharon G McDowall; Frederick A O Mendelsohn; Michelle Brennan; Rebecca A Lew; Anthony L Albiston; Siew Yeen Chai
Journal:  J Pharmacol Exp Ther       Date:  2003-04       Impact factor: 4.030

7.  Synergistic modulation of cystinyl aminopeptidase by divalent cation chelators.

Authors:  Heidi Demaegdt; Hilde Laeremans; Jean-Paul De Backer; Sabrina Mosselmans; Minh Tam Le; Veerle Kersemans; Yvette Michotte; Georges Vauquelin; Patrick M L Vanderheyden
Journal:  Biochem Pharmacol       Date:  2004-09-01       Impact factor: 5.858

8.  Angiotensin AT4 ligands are potent, competitive inhibitors of insulin regulated aminopeptidase (IRAP).

Authors:  Rebecca A Lew; Tomris Mustafa; Siying Ye; Sharon G McDowall; Siew Yeen Chai; Anthony L Albiston
Journal:  J Neurochem       Date:  2003-07       Impact factor: 5.372

Review 9.  Role of the insulin-regulated aminopeptidase IRAP in insulin action and diabetes.

Authors:  Susanna Renata Keller
Journal:  Biol Pharm Bull       Date:  2004-06       Impact factor: 2.233

10.  Endogenous cystinyl aminopeptidase in Chinese hamster ovary cells: characterization by [125I]Ang IV binding and catalytic activity.

Authors:  Heidi Demaegdt; Patrick Vanderheyden; Jean-Paul De Backer; Sabrina Mosselmans; Hilde Laeremans; Minh Tam Le; Veerle Kersemans; Yvette Michotte; Georges Vauquelin
Journal:  Biochem Pharmacol       Date:  2004-09-01       Impact factor: 5.858

View more
  3 in total

1.  Translocation of the insulin-regulated aminopeptidase to the cell surface: detection by radioligand binding.

Authors:  H Demaegdt; L Smitz; J-P De Backer; M T Le; M Bauwens; E Szemenyei; G Tóth; Y Michotte; P Vanderheyden; G Vauquelin
Journal:  Br J Pharmacol       Date:  2008-04-21       Impact factor: 8.739

2.  Discovery of inhibitors of insulin-regulated aminopeptidase as cognitive enhancers.

Authors:  Hanna Andersson; Mathias Hallberg
Journal:  Int J Hypertens       Date:  2012-12-04       Impact factor: 2.420

Review 3.  From Angiotensin IV to Small Peptidemimetics Inhibiting Insulin-Regulated Aminopeptidase.

Authors:  Mathias Hallberg; Mats Larhed
Journal:  Front Pharmacol       Date:  2020-10-15       Impact factor: 5.810

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.